Covid cases, controls spread in China

Covid cases, controls spread in China


Covid cases and controls have increased in China this month. Pictured here on Oct. 27, 2022, is a neighborhood in Shanghai that’s been fenced in for Covid control.

Future Publishing | Future Publishing | Getty Images

BEIJING — Covid controls in China have tightened in the last two weeks after more cities reported virus outbreaks.

The restrictions on business and social activity affected 9.2% of China’s gross domestic product as of Thursday, up from 7% on Oct. 16, according to Nomura’s model.

“Since the 20th National Party Congress kicked off on 16 October, domestic Covid case numbers have been clearly on an upward trajectory,” the firm’s chief China economist Ting Lu and a team said in a report Thursday. “The national lockdown situation has been getting … significantly worse.”

For Thursday, mainland China reported 214 Covid cases with symptoms and 1,123 without. The infections were reported in well over 20 of China’s 31 province-level regions.

Among the many outbreaks nationwide, infections in the capital city forced Universal Beijing Resort to close temporarily starting Wednesday. It was unclear if the resort would re-open in time for Halloween weekend.

Apple supplier Foxconn said Tuesday its factory in Zhengzhou, China, was affected by a small Covid outbreak.

We're seeing weakening consumer sentiment in Europe and China: Unilever CEO

However, many of the recent case clusters and ensuing Covid controls have occurred in less economically prominent parts of the country, such as areas within Qinghai and Xinjiang in the northwest.

The Nomura report also pointed out that some localities have not directly announced lockdown measures, making it difficult to assess the impact.

Little change on Covid after China’s big meeting

Read more about China from CNBC Pro

Fourth-quarter growth calls



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More